Status:
UNKNOWN
The Effect of Monitoring PVP on Clinical Outcomes in Patients With PH
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Portal Hypertension
Eligibility:
All Genders
18-80 years
Brief Summary
The complications associated with portal hypertension in cirrhosis are the main cause of death in patients with cirrhosis. The level of portal venous pressure is closely related to the prognosis of pa...
Eligibility Criteria
Inclusion
- With chronic liver disease
- Age 18-80 years
- Patients who require a portal pressure measurement at the discretion of the treating physician
- Voluntarily signed informed consent
Exclusion
- With serious cardiopulmonary disease or other diseases affect survival
- With severe renal dysfunction
- Concomitant portal vein cavernous degeneration or extensive portal vein thrombosis
- Women who are planning to become pregnant or who are pregnant or breastfeeding
- The researcher judged that it was not suitable to participate in this study
Key Trial Info
Start Date :
March 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04820166
Start Date
March 12 2021
End Date
December 31 2025
Last Update
March 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital
Guangzhou, Guangdong, China